Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• New cholesterol guidelines offer more personalized risk calculation, endorse nonstatin therapy
• 2018: A year of enhanced understanding about risk, personalized treatment Carl J. Pepine, MD, MACC
• New advances in preventive cardiology: A critical appraisal of 2018 cholesterol guidelines
• ACC: SGLT2 inhibitors, GLP-1 agonists reduce CV risk in type 2 diabetes
• AHA: Statin benefits outweigh risks
• Barbershop intervention sustains BP reductions in black men at 1 year
• Cardiogenic shock confers worse outcomes in takotsubo cardiomyopathy
• Community-based intervention lowers BP in Hispanic patients with stroke
• Frequent, earlier influenza vaccinations reduce death risk in HF
• Genomic risk score predicts CAD better than conventional factors
• Stroke risk differs by race, sex groups
• Variant in titin gene linked to early-onset AF
• Cardiology Today’s Editorial Board discusses top news of 2018
• Antisense oligonucleotide reduces Lp(a) in patients at high residual risk
• EWTOPIA75: Ezetimibe prevents CV events in elderly Japanese patients
• Low-dose rivaroxaban reduces thromboembolic events in certain patients with HF
• Performance during exercise echocardiography predicts mortality risk
• PRINCESS: Transnasal cooling safe, may improve outcomes in out-of-hospital cardiac arrest
• CATCH2
• EARLY
• EVADE CAD
• PRINCESS
• TiCAB
• TRED-HF
• T-TIME
• VIPVIZA